Zusammenfassung
Bei der Hypertonie in der Schwangerschaft ist zwischen der eigentlichen schwangerschaftsassoziierten Hypertonie und einer vorbestehenden essentiellen oder sekundären arteriellen Hypertonie, z. B. bei vorbestehenden Nierenerkrankungen oder Kollagenosen, zu differenzieren.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Abalos E, Duley L, Steyn DW, Henderson-Smart DJ (2001) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2:CD002252
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369(9575):1791–1798
AWMF. Leitlinien für Diagnostik und Therapie der Deutschen Gesellschaft für Gy- näkologie und Geburtshilfe (DGGG): Diagnostik und Therapie hypertensi- ver Schwangerschaftserkrankungen. Erarbeitungsdatum 02/2007. Letzte Überarbeitung 05/2008. Düsseldorf: AWMF; 2008
Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298(6673):564–567
Chang J, Streitman D (2012) Physiologic adaptations to pregnancy. Neurol Clin 30(3):781–789
Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354(23):2443–2451
Davison JM, Homuth V, Jeyabalan A et al (2004) New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 15(9):2440–2448
Dechend R, Luft FC (2008) Angiogenesis factors and preeclampsia. Nat Med 14(11):1187–1188
Dechend R, Viedt C, Muller DN et al (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107(12):1632–1639
Duley L, Henderson-Smart D, Meher S (2005) Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev 4:CD005548
Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H (2012) The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem 58(5):837–845
Henzel MK, Alsip NL (2001) Systemic vascular reactivity in an aortic coarctation model of preeclampsia in the rat. Pathophysiology 8(2):133–140
Homuth V, Derer W, Dechend R (2009) Hypertension and pregnancy. Dtsch Med Wochenschr 134(5):195–200
Imbasciati E, Gregorini G, Cabiddu G et al (2007) Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 49(6):753–762
Jones DC, Hayslett JP (1996) Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 335(4):226–232
Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367(9516):1066–1074
Khraibi AA (2002) Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy. J Hypertens Suppl 20(3):S21–S27
Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672–683
Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005
Luft FC (2003) Pre-eclampsia and the maternal cardiovascular risk. Nephrol Dial Transplant 18(5):860–861
Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S (2011) How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 72(3):394–401
Meher S, Abalos E, Carroli G (2005) Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev 4:CD003514
Odutayo A, Hladunewich M (2012) Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol 7(12):2073–2080
Redman CW (2011) Hypertension in pregnancy: the NICE guidelines. Heart 97(23):1967–1969
Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361(9368):1511–1517
Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE (1996) Preeclampsia – a state of sympathetic overactivity. N Engl J Med 335(20):1480–1485
Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB (1994) The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171(4):944–948
Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335(4):257–265
Verlohren S, Geusens N, Morton J et al (2010) Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 56(2):304–310
Wacker JR, Wagner BK, Briese V et al (2006) Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 127(2):160–165
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Hausberg, M. (2015). Hypertonie in der Schwangerschaft. In: Lehnert, H., et al. DGIM Innere Medizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_284-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-54676-1_284-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54676-1
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Hypertonie in der Schwangerschaft- Published:
- 25 February 2020
DOI: https://doi.org/10.1007/978-3-642-54676-1_284-2
-
Original
Hypertonie in der Schwangerschaft- Published:
- 23 April 2015
DOI: https://doi.org/10.1007/978-3-642-54676-1_284-1